Holen Sie sich die Stockscreener-App
0.6651
2.61%
-0.0178
Handel nachbörslich:
.68
0.0149
+2.24%
Schlusskurs vom Vortag:
$0.6829
Offen:
$0.68
24-Stunden-Volumen:
37,936
Relative Volume:
0.12
Marktkapitalisierung:
$18.00M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-1.40M
KGV:
-3.2068
EPS:
-0.2074
Netto-Cashflow:
$-10.49M
1W Leistung:
+3.28%
1M Leistung:
-20.73%
6M Leistung:
-92.63%
1J Leistung:
+0.00%
1-Tages-Spanne:
$0.6651
$0.7018
1-Wochen-Bereich:
$0.61
$0.739
52-Wochen-Spanne:
$0.61
$33.66
Liminatus Pharma Inc Stock (LIMN) Company Profile
Firmenname
Liminatus Pharma Inc
Sektor
Branche
Telefon
213-273-5453
Adresse
6 CENTERPOINTE DR., LA PALMA
Vergleichen Sie LIMN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LIMN
Liminatus Pharma Inc
|
0.6651 | 18.48M | 0 | -1.40M | -10.49M | -0.2074 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Liminatus Pharma Inc Aktie (LIMN) Neueste Nachrichten
Inhibikase Therapeutics (NASDAQ:IKT) vs. Liminatus Pharma (NASDAQ:LIMN) Financial Survey - Defense World
Liminatus Pharma files to sell 6.9M shares of common stock - MSN
Liminatus Pharma Stock Surges to Record High After Regaining Nasdaq Compliance - MSN
What is the current Price Target and Forecast for Liminatus Pharma Inc. (LIMN) - Zacks Investment Research
Contrasting Inhibikase Therapeutics (NASDAQ:IKT) and Liminatus Pharma (NASDAQ:LIMN) - Defense World
Can Liminatus Pharma Inc. Equity Warrant stock beat market expectations this quarterTreasury Yields & Reliable Trade Execution Plans - Bölüm Sonu Canavarı
Inhibikase Therapeutics (NASDAQ:IKT) and Liminatus Pharma (NASDAQ:LIMN) Head to Head Contrast - Defense World
Analyzing Liminatus Pharma (NASDAQ:LIMN) and Inhibikase Therapeutics (NASDAQ:IKT) - Defense World
Can Liminatus Pharma Inc. stock beat market expectations this quarterMarket Activity Report & Weekly High Return Forecasts - Улправда
Should I hold or sell YORW stock in 2025Trade Performance Summary & Reliable Entry Point Trade Alerts - moha.gov.vn
Published on: 2025-12-21 01:33:15 - Улправда
Will Liminatus Pharma Inc. Equity Warrant stock maintain dividend yieldPortfolio Risk Summary & Capital Efficient Trade Techniques - bolumsonucanavari.com
Market Pulse: What Wall Street predicts for Liminatus Pharma Inc. stock priceTrade Exit Summary & High Yield Stock Recommendations - Bölüm Sonu Canavarı
Is Liminatus Pharma Inc. stock oversold or undervaluedJuly 2025 Catalysts & High Conviction Buy Zone Picks - Улправда
How Liminatus Pharma Inc. Equity Warrant stock compares to industry benchmarks2025 Price Action Summary & Short-Term High Return Ideas - Улправда
Is Liminatus Pharma Inc. stock in correction or buying zone2025 Growth vs Value & Reliable Entry Point Alerts - Улправда
Can Liminatus Pharma Inc. stock outperform in 2025 bull market2025 Year in Review & Safe Investment Capital Preservation Plans - Улправда
Published on: 2025-12-19 21:14:50 - Улправда
Why Liminatus Pharma Inc. Equity Warrant stock is in analyst buy zoneQuarterly Risk Review & Real-Time Volume Surge Alerts - Bölüm Sonu Canavarı
What Wall Street predicts for Liminatus Pharma Inc. stock priceQuarterly Investment Review & Verified Swing Trading Watchlist - DonanımHaber
Will Liminatus Pharma Inc. stock benefit from AI adoptionQuarterly Trade Review & Risk Controlled Swing Trade Alerts - DonanımHaber
Can Liminatus Pharma Inc. stock hit record highs again2025 Price Momentum & Trade Opportunity Analysis - DonanımHaber
Will Liminatus Pharma Inc. stock see insider buyingWeekly Trading Summary & Growth Focused Entry Reports - DonanımHaber
What insider trading reveals about Liminatus Pharma Inc. stockWeekly Profit Analysis & Weekly Top Performers Watchlists - DonanımHaber
Why Liminatus Pharma Inc. Equity Warrant stock remains on buy listsPrice Action & High Accuracy Investment Signals - Улправда
Bear Alert: Can Liminatus Pharma Inc stock hit record highs againJuly 2025 Reactions & Low Drawdown Trading Strategies - moha.gov.vn
Is Liminatus Pharma Inc. Equity Warrant stock a buy for dividend growthDollar Strength & Verified High Yield Trade Plans - Улправда
Published on: 2025-12-18 21:46:16 - Улправда
Published on: 2025-12-18 20:43:25 - Улправда
Contrasting Inhibikase Therapeutics (NASDAQ:IKT) & Liminatus Pharma (NASDAQ:LIMN) - Defense World
Investment Recap: Will Liminatus Pharma Inc stock benefit from AI adoptionPrice Action & AI Forecasted Entry and Exit Points - moha.gov.vn
Liminatus Pharma (LIMNW) Stock Analysis Report | Financials & Insights - Benzinga
LIMNW Stock Institutional Owners - Quiver Quantitative
Will Liminatus Pharma Inc. stock reach Wall Street targetsPortfolio Risk Summary & Daily Stock Trend Watchlist - Newser
What sentiment indicators say about Liminatus Pharma Inc. Equity Warrant stockEarnings Trend Report & Real-Time Buy Signal Alerts - Newser
Is Liminatus Pharma Inc. stock trading at a premium valuationTrade Risk Summary & Consistent Return Strategy Ideas - Newser
Chart Watch: Can TriCo Bancshares stock beat market expectations this quarterCPI Data & Daily Volume Surge Signals - BỘ NỘI VỤ
Reviewing Vor Biopharma (NASDAQ:VOR) and Liminatus Pharma (NASDAQ:LIMN) - Defense World
Will Liminatus Pharma Inc. Equity Warrant stock outperform Dow Jones indexPortfolio Gains Summary & Risk Controlled Daily Plans - moha.gov.vn
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Liminatus Pharma Faces Nasdaq Non-Compliance Notice - MSN
Liminatus Pharma receives Nasdaq notice for non-compliance with listing standards - Investing.com India
LIMN gets Nasdaq warnings over market value and listing rules - Stock Titan
Holdings of Chegg Inc (CHGG) are aligned with the stars - Setenews
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Views of Wall Street’s Leading Experts on Liminatus Pharma Inc - Setenews
Published on: 2025-11-24 07:40:26 - earlytimes.in
What analysts say about Liminatus Pharma Inc Equity Warrant stockTechnology Stock Trends & Free Get High Impact Recommendations - earlytimes.in
Liminatus Pharma (NASDAQ:LIMN) versus Prime Medicine (NASDAQ:PRME) Head to Head Comparison - Defense World
Liminatus Pharma (NASDAQ:LIMN) Downgraded by Wall Street Zen to Strong Sell - Defense World
Midday Stock Roundup: RxSight up 14% - Orange County Business Journal
Finanzdaten der Liminatus Pharma Inc-Aktie (LIMN)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):